View : 148 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author윤주영-
dc.date.accessioned2020-12-14T16:30:08Z-
dc.date.available2020-12-14T16:30:08Z-
dc.date.issued2021-
dc.identifier.issn0142-9612-
dc.identifier.otherOAK-28298-
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/255713-
dc.description.abstractImmunogenic photodynamic therapy (PDT) has the potential to moderate the shortfalls of cancer immunotherapy. However, its efficacy is severely limited particularly because of the lack of optimal photosensitizers and smart delivery processes and the inherent shortcomings of PDT (e.g., hypoxia resistance). Here, we demonstrate a clinically promising approach that utilizes a water-soluble phthalocyanine derivative (PcN4) concomitantly delivered with a hypoxia-activated prodrug (AQ4N) to amplify the effect of PDT and enhance cancer immunotherapy. After intravenous injection, PcN4 selectively interacted with endogenous albumin dimers and formed supramolecular complexes, providing a facile and green approach for tumor-targeted PDT. The concomitant delivery of AQ4N overcame the limitations of hypoxia in PDT and improved the antitumor activity of PDT. Treatment with PcN4-mediated and AQ4N-amplified PDT almost completely eradicated sizable primary tumors in a triple-negative breast cancer model and significantly activated CD8+ T cells. As the majority of tumor infiltrating CD8+ T cells were both PD-1- and TIM3-positive, additional combination therapy using PD-L1/PD-1 pathway blockade was warranted. After combination with immune checkpoint blockade treatment, an enhanced abscopal effect was achieved in both distant and metastatic tumors. © 2020 Elsevier Ltd-
dc.languageEnglish-
dc.publisherElsevier Ltd-
dc.subjectCancer immunotherapy-
dc.subjectHypoxia-activated prodrug-
dc.subjectPhotodynamic therapy-
dc.subjectPhthalocyanine-
dc.subjectSupramolecular self-assembly-
dc.titleIn Vivo-assembled phthalocyanine/albumin supramolecular complexes combined with a hypoxia-activated prodrug for enhanced photodynamic immunotherapy of cancer-
dc.typeArticle-
dc.relation.volume266-
dc.relation.indexSCIE-
dc.relation.indexSCOPUS-
dc.relation.journaltitleBiomaterials-
dc.identifier.doi10.1016/j.biomaterials.2020.120430-
dc.identifier.wosidWOS:000591614100004-
dc.identifier.scopusid2-s2.0-85091950487-
dc.author.googleLi X.-
dc.author.googleJeon Y.-H.-
dc.author.googleKwon N.-
dc.author.googlePark J.-G.-
dc.author.googleGuo T.-
dc.author.googleKim H.-R.-
dc.author.googleHuang J.-D.-
dc.author.googleLee D.-S.-
dc.author.googleYoon J.-
dc.contributor.scopusid윤주영(7403587371)-
dc.date.modifydate20210929144228-
Appears in Collections:
자연과학대학 > 화학·나노과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE